Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative
Crossref DOI link: https://doi.org/10.1186/s13063-016-1208-5
Published Online: 2016-02-09
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Palmer, Rebecca
Harrison, Madeleine
Cross, Elizabeth
Enderby, Pam
Funding for this research was provided by:
National Institute for Health Research (GB) (12/21/01AB)